Clinical Trial Update: Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluates whether Seroquel-XR (quetiapine extended-release) improves neurocognitive function in people at risk for schizophrenia with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Severance Hospital | Conditions: Abnormal Mental State, Schizophrenia | Phase 4 | Status: UNKNOWN